ArticleBMC rheumatology2026
Preferences, experiences and needs regarding tobacco cessation expressed among patients with rheumatoid arthritis: a qualitative study.
Article in BMC rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSmoking presents significant challenges for individuals with rheumatoid arthritis (RA) yet understanding of their smoking habits and perceptions remains limited. This study explores preferences regarding tobacco cessation strategies, barriers to success in cessation, and perceived needs in this population.
methodsWe conducted qualitative semi-structured interviews with 16 people with RA (9 past and 7 current tobacco users). Data were analyzed to identify common themes and patterns related to smoking behaviors and perceptions.
resultsMost participants did not alter their smoking habits after developing RA, and common triggers for smoking included alcohol consumption, coffee, stress, and RA symptoms. Few used non-combustible tobacco products, but many attempted nicotine replacement methods. Participants generally perceived smoking as having no role in RA development, although they recognized its negative health impacts, including respiratory and cardiovascular issues. Despite advice from healthcare providers, many participants were not ready to quit smoking, citing addiction, past failures, and challenges in replacing smoking with other activities as major barriers. Motivations and facilitators for quitting included family needs and support, health concerns, and financial savings. Successful quitters identified the need for strong personal commitment, use of medical aids, behavioral changes, and social support. Effective cessation programs should include education about health impacts and medication use, interactive discussions, support groups, and flexible formats, participants said.
conclusionsSmoking behaviors in individuals with RA are influenced by multiple factors, including stress, RA symptoms, and addiction. Effective cessation programs should address these specific challenges by incorporating personalized education, behavioral support, and flexible formats. Understanding these dynamics can improve targeted interventions to support RA patients in quitting smoking and managing their health more effectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.